A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Researchers have a new hope for preventing severe illness from the bird flu after finding a groundbreaking antibody treatment ...

In the U.S. public health system, local and state health departments collect and own the data rather than the federal ...

The finding indicates that the virus, known as H5N1, has spilled from birds into cows at least twice — leading to these two ...

There's widespread confusion and fear among scientists and doctors on the sprawling National Institutes of Health campus and at institutions dependent on the agency's funding.

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

A House committee will hold a hearing this week scrutinizing whether National Institutes of Health animal research amounts to ...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...

HealthTech Arkansas and MedAxiom have launched year four of HeartX, a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for ...

Castillo Engineering announced that it has been selected by Montante Solar to provide design and engineering services on two of Calibrant Energy's landfill community solar projects in Niagara, New ...

A human pandemic is not inevitable even now, more than a dozen experts said in interviews. Read more at straitstimes.com.